(jofem.org) The best-case signal: modest weight loss in a shorter trial A frequently cited 12-week randomized trial result (as summarized in reviews) reported: ~2.6 kg average loss with AOD-9604 1 mg/day vs ~0.8 kg with placebo (PMC) This is the kind of result that can be statistically meaningful, clinically modest, and very sensitive to study design (diet, activity, baseline metabolic status, adherence)
You get a series of B12 shots, day-in and day-out, as a way to replenish your body with the B12 that it cant absorb through the stomach
Researchers may utilize AHK-Cu in cell culture models, dermal biology assays, follicular microenvironment studies, wound-repair pathway investigations, and broader experiments involving peptide-mediated copper transport and cellular adaptation
Cost varies by formulation, dose, and pharmacy